General practitioners working in Dubai have been granted authorisation to practice minor cosmetic procedures following training for the first time.
A study presented at the America Society for Dermatologic Surgery annual meeting has shown that combining the use of gold microparticles with laser-mediated photothermolysis and topical retinoids was associated with a 61% reduction in inflammatory lesion count at three months amongst patients with mild to moderate acne vulgaris.
US-based skincare brand Medicalia is now available to practitioners in the UK and Ireland from product distributor Pevonia.
Social media platform Instagram will be hiding the number of likes on some posts in the UK, as part of a global trial that aims to remove pressures on users.
A campaign aiming to empower and equip rosacea patients to discuss the true burden of their disease with a dermatologist called Face Up To Rosacea has launched.
A study conducted by A Lallas et al., published in the Journal of the American Academy of Dermatology has found there to be an 8% risk for second primary melanoma within five years.
Members of the British Association of Cosmetic Nurses (BACN) have voted unanimously to update its Code of Conduct on the training of beauty therapists.
Global pharmaceutical company Galderma’s liquid formulation of botulinum toxin type A has achieved positive results for the treatment of glabellar lines in a phase 2 clinical trial.
The British Skin Foundation, a charity dedicated to raising funds for skin disease research, has conducted a survey amongst 245 dermatologists indicating that 87% believe that there is a lack of access to psychological support for those suffering with skin conditions in the UK.
A pilot study of 18 male patients has demonstrated an increase in hair density and thickness following botulinum toxin treatment.